Search
News
Important Only
Instacart Posts Q1 Revenue $1.02 Billion Vs. IBES Estimate $1.01 Billion
May 6 (Reuters) - Maplebear Inc CART.O:INSTACART Q1 EPS $0.57 VERSUS. IBES ESTIMATE $0.60INSTACART Q1 ADJUSTED EBITDA $300 MILLION VERSUS IBES ESTIMATE $287.4 MILLIONINSTACART OUTLOOK Q2 GTV $10.10 BILLION TO $10.25 BILLION VERSUS IBES ESTIMATE $10.07 BILLIONINSTACART Q1 REVENUE $1.02 BILLION VERSUS...Reuters
Wed, May 6
Strata Critical Medical Q1 revenue jumps 87%, beats estimates
OverviewUS time-critical medical logistics provider's Q1 revenue rose 87% yr/yr, beating analyst expectationsAdjusted EBITDA for Q1 was $6.4 mln, up sharply from prior yearCompany completed acquisition of Ohio Valley Perfusion Associates and reiterated 2026 guidanceOutlookStrata Critical Medical...Reuters
Wed, May 6
Canada's Sprott Q1 revenue rises, driven by higher AUM and performance fees
OverviewCanada asset manager's Q1 revenue rose year-over-year, driven by higher AUM and performance feesQ1 adjusted EBITDA and net income increased sharply from a year earlierCompany declared a quarterly dividend of $0.40 per shareOutlookCompany says near-term volatility in gold and silver price...Reuters
Wed, May 6
Performance Food Q3 revenue rises 6.4%, slightly beats estimates
OverviewU.S. food distributor's fiscal Q3 revenue rose 6.4%, slightly beating analyst expectationsAdjusted EPS for fiscal Q3 rose 1.3% to $0.80, beating analyst expectationsNet income for fiscal Q3 fell 28.5% due to higher operating expensesOutlookCompany narrows FY 2026 net sales guidance to $6...Reuters
Wed, May 6
Brinks Q1 revenue rises 10%, beats analyst expectations
OverviewUS cash management firm's Q1 revenue rose 10%, beating analyst expectationsAdjusted EPS for Q1 beat consensus, driven by AMS/DRS segment growth and margin expansionCompany says NCR Atleos acquisition remains on track to close by end of Q1 2027OutlookBrinks sees Q2 2026 revenue between $1...Reuters
Wed, May 6
BioCryst Q1 ORLADEYO revenue rises 11%, net loss widens
OverviewUS rare disease drugmaker's Q1 ORLADEYO revenue rose 11% yr/yr, driven by new prescriptionsGAAP net loss widened on special, non-cash charge from Astria Therapeutics acquisitionCompany announced $70 mln upfront licensing deal for European navenibart rights, plus potential milestonesOutlo...Reuters
Wed, May 6
Royalty Pharma Q1 adjusted EBITDA misses analyst estimates
OverviewBiopharma royalty buyer's Q1 Portfolio Receipts rose 10% yr/yr, Royalty Receipts up 13%Adjusted EBITDA for Q1 missed analyst expectationsCompany raised full-year 2026 Portfolio Receipts guidanceOutlookRoyalty Pharma raises 2026 Portfolio Receipts guidance to $3,325 mln-$3,450 mlnCompany ...Reuters
Wed, May 6
Bio-Techne misses revenue estimates as US academic funding cuts dent demand
May 6 (Reuters) - Biotech firm Bio-Techne TECH.O on Wednesday missed Wall Street estimates for third-quarter revenue, as cuts to U.S. academic funding weighed on demand for its drug-development products.Here are some details: The Minneapolis, Minnesota-based company, develops products used in medica...Reuters
Wed, May 6
J & J Snack Foods Q2 sales fall 3%, slightly miss estimates
OverviewUS snack foods maker's Q2 sales fell 3.2%, slight miss to analyst expectationsAdjusted EPS for Q2 rose 14% yr/yr but missed analyst expectationsCompany repurchased $22 mln in stock during the quarterOutlookCompany did not provide specific financial guidance for the current or upcoming pe...Reuters
Wed, May 6
Advantage Solutions Q1 revenue rises
OverviewUS retail solutions agency's Q1 revenue rose 5.8% year-over-yearAdjusted EBITDA for Q1 grew 16.4%, driven by Experiential and Retailer ServicesCompany reaffirmed 2026 guidance for revenue, adjusted EBITDA and cash flowOutlookAdvantage Solutions expects 2026 revenues to be flat to up low ...Reuters
Wed, May 6
UK's Immunocore Q1 profit beats estimates
OverviewUK biotechnology firm's Q1 EPS, net income and operating income all beat analyst expectationsKIMMTRAK net product sales grew 14% yr/yr, driven by higher volumes and global expansionCompany ended Q1 with $845 mln in cash, cash equivalents and marketable securitiesOutlookCompany expects to...Reuters
Wed, May 6
Canada's Kits Eyecare Q1 revenue rises 23% to record
OverviewCanada eyecare platform's Q1 revenue rose 23% yr/yr to record C$57.5 mlnNet income for Q1 increased 23% to C$2.0 mlnQ1 glasses revenue jumped 61% yr/yr, driven by higher unit sales and premium upgradesOutlookKits Eyecare expects Q2 revenue between $57.0 mln and $59.0 mlnCompany sees Q2 A...Reuters
Wed, May 6
EyePoint Pharmaceuticals Q1 net loss widens on increased R&D spending
OverviewUS biopharma firm's Q1 revenue dropped sharply due to prior year licensing revenue recognitionQ1 net loss widened as R&D and manufacturing costs rose for DURAVYU Phase 3 trialsCompany ended Q1 with $223 mln in cash and investments, runway into Q4 2027OutlookEyePoint expects topline d...Reuters
Wed, May 6
Spire Q2 net income rises, cuts 2026 EPS guidance
OverviewU.S. natural gas utility's fiscal Q2 net income and adjusted EPS rose yr/yrCompany completed Piedmont Tennessee acquisition, agreed to sell non-core businessesSpire cut fiscal 2026 adjusted EPS guidance, reaffirmed long-term growth targetsOutlookSpire lowers fiscal 2026 adjusted EPS guid...Reuters
Wed, May 6
Israel's InMode Q1 adjusted profit misses, hurt by higher costs
OverviewIsrael medical device maker's Q1 revenue rose 5%, beating analyst expectationsAdjusted EPS and net income for Q1 missed analyst expectationsCompany completed $34.8 mln share repurchase and announced CFO and board changesOutlookInMode expects 2026 revenue between $365 mln and $375 mlnComp...Reuters
Wed, May 6
Instacart Q1 revenue rises 14%, beats estimates
OverviewU.S. grocery technology platform's Q1 revenue rose 14% yr/yr, beating analyst expectationsAdjusted EPS missed analyst expectationsCompany repurchased $349 mln in shares during the quarterOutlookInstacart sees Q2 2026 GTV between $10.1 bln and $10.25 blnCompany expects Q2 2026 Adjusted EB...Reuters
Wed, May 6
TG Therapeutics Q1 revenue rises, lifts 2026 outlook
OverviewUS biotech firm's Q1 product revenue rose yr/yr, driven by BRIUMVI salesQ1 net income increased to $19.8 mln from $5.1 mln a year agoCompany raised 2026 global revenue and BRIUMVI U.S. sales guidanceOutlookTG Therapeutics raises 2026 total global revenue target to $925 mlnCompany raises ...Reuters
Wed, May 6
Lifecore Biomedical Q1 revenue falls 34%, misses analyst estimates
OverviewU.S. injectables CDMO's Q1 revenue fell 34% yr/yr, missing analyst expectationsNet loss per share widened to $0.43 from $0.42 yr/yrCompany reaffirmed 2026 revenue and adjusted EBITDA guidanceOutlookLifecore Biomedical expects 2026 revenue between $120 mln and $125 mlnCompany sees 2026 Ad...Reuters
Wed, May 6
New York Times tops Q1 profit estimates on digital growth
OverviewUS news publisher's Q1 adjusted EPS beat analyst expectations, driven by digital subscription growthAdjusted operating profit for Q1 beat analyst expectationsCompany repurchased 779,365 shares for $56.3 mln during the quarterOutlookCompany expects Q2 digital-only subscription revenues to...Reuters
Wed, May 6
Kyndryl Q4 revenue slightly beats estimates, adjusted EBITDA tops forecasts
OverviewU.S. enterprise tech services firm's fiscal Q4 revenue slightly beat analyst expectationsAdjusted EBITDA for fiscal Q4 beat analyst estimatesCompany repurchased 11.6 mln shares in fiscal 2026, including 3.3 mln in Q4OutlookKyndryl sees fiscal 2027 adjusted pretax income of $600 mln to $7...Reuters
Wed, May 6
Featured Tools
Top News
April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide
PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today
Kospi Plunges Over 5% After Nearing 8,000 Points as South Korean Top Official Proposes ‘AI Profit Redistribution’
Samsung’s Largest Strike in History: Can SK Hynix and Micron Sit Back and Reap the Benefits?
S&P and Nasdaq Hit New Highs on Chip Rally, But Michael Burry Warns of Looming Stock Crash
Market Movers
Amphenol Corp Stock (APH) Closed Up by 3.40% on May 14: Facts Behind the Movement
50 minutes ago
APH
--
Micron Technology Inc Stock (MU) Closed Down by 3.06% on May 14: Key Drivers Unveiled
50 minutes ago
MU
--
Tradingkey
